Svetinorm
Liver peptide bioregulator
Svetinorm (Liver peptide bioregulator) is a longevity & bioregulators research compound. Liver bioregulator — proposed to support hepatocyte function and detoxification capacity.
Svetinorm quick facts
| Reported research dose (Injectable) | 2mg-5mg (per course) |
| Route | Subq |
| Frequency | 1x Daily · Daily (course) |
| Half-life | ~15-30 min |
| Forms | Injectable, Oral |
| Evidence level | Russian studies; limited |
| Other forms available | Oral — dosed differently |
Liver cytogen — course-based hepatic support. The liver does the work almost nothing else can be substituted for — drug clearance, protein synthesis, bile. This is aimed at hepatocyte function rather than at 'detox' in the marketing sense. Course pattern: roughly 10 days on, then off, once or twice a year. To know whether it did anything, a CMP gives you ALT, AST and bilirubin before and after. Run it as an experiment you measure, not a protocol you trust.
How Svetinorm works
Liver bioregulator — proposed to support hepatocyte function and detoxification capacity.
Proposed benefits
Researched for mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
Where to get Svetinorm
Bacteriostatic water is the diluent — sterile water with 0.9% benzyl alcohol, which is what lets a vial be drawn from more than once. It does not come with the vial, and unlike the compound it is bought again every time.
Need bacteriostatic water? Get it at AminoWell USA (my company) → Code CAMERON.
The evidence for Svetinorm
Graded by what exists behind each claim.
Human clinical evidence
- The human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
📊 Correlative data
- The liver extract, sold for hepatocyte function and detoxification capacity. Occupies the same space as Ovagen without a defined sequence.
- Beyond that the record is self-reported: community dosing logs are real information about tolerability and almost none about efficacy.
🧪 Theoretical / extrapolated
- A liver-derived peptide complex proposed to support hepatocyte function.
- Two things at once: the mechanism is a real, testable hypothesis with published cell-level work behind it, and essentially all of that work is one group's, unreplicated at scale.
- 'Detoxification capacity' is doing a lot of unearned work in the marketing — the liver's phase I and phase II enzyme systems are measurable and specific, and nothing published shows this preparation moves any of them. Liver enzymes on a standard panel remain the honest test.
What community dosing logs are worth → · How to read the Soviet clinical series → · The Khavinson series, in full →
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Svetinorm actually does
The liver arm of this catalog has 2 products and neither has liver evidence. That is the honest headline and it takes 2 sentences to justify. Svetinorm is an undefined liver-tissue peptide complex with nothing indexed under its trade name. Ovagen is a defined tripeptide, Glu-Asp-Leu, whose entire published animal literature is about the kidney. So a buyer choosing between them is choosing between no data and data for a different organ.
What a complex is. Liver tissue, extracted and size-fractionated, standardized by total peptide content rather than by composition. No sequence, so no formula, no exact mass, no isoelectric point, no computable charge at blood pH. Every quantitative argument this site makes about the defined peptides — 375.39 Da and a net charge near −2.06 for the tripeptide next door — is unavailable here, and a certificate of analysis cannot supply it, because sterility and total protein do not identify a mixture.
The delivery problem is the sharpest in the catalog for this one, and the reason is that the liver is where absorbed material goes first. The named route across the gut epithelium is PEPT1, described as carrying di- and tripeptides Khavinson 2022, and everything crossing it enters the portal vein and reaches the liver before anything else. For most oral products in this catalog hepatic first-pass extraction is a loss. For a liver product it is the opposite: first-pass extraction concentrates material in exactly the target organ. This is the one page where the standard pharmacokinetic objection turns into an argument in the product's favor, and no vendor makes it, presumably because nobody selling this has thought about portal circulation. It is a hypothesis with 0 measurements behind it and it is still better reasoning than what is currently printed.
What the class proposes once inside. Transcriptional regulation in the target tissue, with peptides reaching chromatin Khavinson 2021, and a structural argument about how a short peptide could recognize a DNA sequence at all Kolchina 2019. Both are about defined molecules. Neither can be applied to a mixture whose contents nobody has published.
Cell, rodent, human — and where it stops
The count. 0 randomized trials, 0 controlled trials, 0 animal studies, 0 mechanism papers indexed under this trade name. A PubMed-restricted search across the oral extract line on this site returns 1 record between 4 of the products and it is about bladder function.
What gets borrowed, and from where. The human evidence invoked for this family comes from injected thymus and pineal preparations given over 6 to 8 years Khavinson 2003 — different organs, different products, a different route. The independent outside view pooled 24 randomized trials over 2,245 participants and rated risk of bias moderate to high with certainty of evidence low to very low, on cognitive endpoints Alsulaimani 2021. Neither touches hepatic function.
The obstacle that makes this page different from the rest. The liver is the organ where the phrase this product is sold on — ‘detoxification capacity’ — is least measurable and most measurable at the same time, depending on which meaning you pick. As a marketing term it names nothing and has no test. As a pharmacological quantity it is completely well defined: it is the rate at which the liver clears a substrate, and it is measured with probe drugs. Caffeine clearance reads CYP1A2. A carbon-13 methacetin or aminopyrine breath test reads microsomal function quantitatively and non-invasively. Indocyanine green clearance reads hepatic blood flow and uptake. All 3 are real, established, quantitative liver function tests, and not one has ever been run on this product or on any product in this family. The gap here is not that the readout does not exist. It is that nobody has used the readouts that do.
What would have to be true, and how you would know it was not
Three predictions, and the first is the one that argues against the way this product is sold.
1. Albumin will not move, and neither will the rest of the CMP, and that is expected rather than disappointing. The liver has enormous functional reserve: albumin and clotting factors only fall when a large fraction of it is gone, which is why they are markers of advanced disease rather than of function in a healthy person. This site retests a CMP every 3 to 6 months on any oral compound. A flat CMP over a course means nothing was damaged, which is worth knowing, and it cannot mean anything was improved.
2. GGT is the marker people will misread, and it needs 6 weeks. GGT responds to alcohol, to weight change, to several medications and to fatty liver, and it has a 2 to 3-week half-life, which is why this site's guidance is 6 weeks minimum after any change before re-drawing it. Anyone who starts a liver peptide and cuts their drinking in the same month has run 2 interventions and can attribute the result to neither. Change 1 thing, wait 6 weeks, draw once.
3. Where a real effect could be looked for, if somebody wanted to. ELF is a serum panel for hepatic fibrosis and this site retests it annually when elevated or at risk; ferritin catches iron overload, which is a treatable cause of raised enzymes that a peptide cannot touch. Neither is a peptide readout — they are the tests that tell you whether the liver problem you are self-treating has a name. That is the honest priority order: find the cause, then argue about the capsule.
What nobody has tested yet
Four experiments, and 2 of them would produce the first quantitative liver data in the history of this product category.
1. Nobody has run a probe-drug clearance test. Caffeine clearance before and after a course, from saliva or plasma samples, is an old and standardized measure of CYP1A2 activity. If this product does anything to hepatic metabolic capacity, that is where it would show, in a number, with units. It has never been measured on any member of this family.
2. Nobody has run a breath test. Carbon-13 methacetin breath testing gives a continuous, non-invasive readout of microsomal liver function within an hour. It is used clinically. Applying it before and after a 30-day course would be the most informative experiment available for this compound and it requires no needle.
3. Nobody has asked whether it interferes with drug metabolism. This is the risk-side twin of experiment 1, and it matters more: a preparation that changed hepatic enzyme activity would change the blood levels of everything else a person takes. There are 0 published interaction studies for this product, and no in-vitro screen against the common cytochrome P450 enzymes, which is a standard, inexpensive assay panel.
4. Nobody has published what is in a capsule. Tandem mass spectrometry on 1 lot gives chain lengths and identifiable sequences. It is the measurement that would let this product be argued about rather than described, and it is the same missing measurement on every extract in this catalog.
Svetinorm — its own safety story, not its class's
Three things specific to a liver preparation.
The interaction question runs the opposite way to the usual one. On most pages the worry is that another drug interferes with the compound. Here the worry is that the compound interferes with everything else, because the liver is where most medication is cleared. Nobody has screened this preparation against the cytochrome P450 enzymes, so a person on a narrow-margin medication — warfarin, an antiepileptic, a transplant drug — is running an untested variable through the organ that sets their blood level. That is a specific and reasonable caution, and it is absent from every vendor page.
Raised liver enzymes deserve a cause, and most causes are findable. Hepatitis B and C, alcohol, hemochromatosis, autoimmune hepatitis, medication effect and metabolic dysfunction-associated steatotic liver disease account for the great majority, and each has a test. Ferritin, a CMP and 2 viral serologies cover most of the list. Substituting an uncharacterized capsule for that workup is the concrete harm on this page.
Provenance and silence. An organ extract begins as animal tissue, which raises sourcing and residual-protein questions that a synthetic tripeptide does not carry and that a sterility certificate does not address. There are 0 published adverse events for this product, and with 0 human studies there has never been a setting in which one could have been recorded — a statement about the evidence base rather than about the capsule.
Sources read for this page
- Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. International Journal of Molecular Sciences 2022;23(14):7733 · PMID 35887081
- Khavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021;26(22):7053 · PMID 34834147
- Kolchina N, Khavinson V, Linkova N, Yakimov A, Baitin D, Afanasyeva A, Petukhov M. Systematic search for structural motifs of peptide binding to double-stranded DNA. Nucleic Acids Research 2019;47(20):10553–10563 · PMID 31598715
- Alsulaimani RA, Quinn TJ (independent — not the Khavinson group). The efficacy and safety of animal-derived nootropics in cognitive disorders: Systematic review and meta-analysis. Cerebral Circulation – Cognition and Behavior 2021;2:100012 · PMID 36324709
- Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinology Letters 2003;24(3-4):233–240 · PMID 14523363
Svetinorm — safety, predicted from mechanism
Predicted from mechanism, not from a human safety trial. How that reasoning works →
What the mechanism predicts
Derived from the molecule, not a trial.
- These are short peptide fragments of organ extracts, and the honest starting point is that the mechanism itself is not established in a way that lets anyone predict harm precisely. The proposal is gene-regulatory — short peptides binding DNA and modulating transcription in a tissue-specific way. If that is what they do, the theoretical concern is influencing transcription in tissue you were not aiming at.
- In practice the doses are tiny, the peptides are short, and they are degraded quickly — which is also the argument that they may do very little at all. Those two possibilities are the same uncertainty viewed from opposite ends, and you should hold both.
What has actually been reported
- Decades of Russian clinical use with a strikingly clean tolerability record — injection-site reactions and little else reported.
- That record comes almost entirely from one research school, is largely unreplicated outside it, and safety data from a group with an interest in the outcome is worth less than the same data from a skeptic. This is not an accusation; it is how evidence weighting works.
How to reduce the risk
Same mechanism as the prediction.
- Follow the course printed on the label rather than running continuously. These are the one class in the Vault where a duration is STATED rather than inferred, and it is typically 10–20 days repeated a few times a year. Read the box.
- Run one at a time. They are cheap and it is tempting to stack six. If something changes, a stack of six tells you nothing about which one did it — and given the evidence base, attribution is the entire value of your own experiment.
- Decide your endpoint before you start, and make it a marker or a measurable symptom rather than a feeling. With a compound class this under-evidenced, an unfalsifiable endpoint means you will conclude it worked no matter what happened.
- Buy from a source that publishes third-party testing. Where the molecule itself is uncertain, identity and purity are the only variables you can actually control.
What it does to your bloodwork
A fact about the assay.
- Test the ORGAN, not the peptide. A thymic peptide is judged on immune markers, a pineal one on sleep and IGF-1, a vascular one on lipids and inflammatory markers. There is no assay for the compound itself.
Don't run this if
- Pregnancy — not because of a specific finding, but because nobody has studied it and the mechanism claim is transcriptional.
- Active malignancy, on the same reasoning as any tissue-growth signal: unproven, mechanistically arguable, and not worth finding out.
The honest unknown
- Essentially everything a skeptic would want: independent replication, pharmacokinetics, and whether the oral forms survive digestion at all. Unproven is not the same as ineffective — but here it is a large unproven.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
Svetinorm — interference & stacking
Predicted from mechanism, not from an interaction study. How mechanism-predicted claims are made →
What Svetinorm moves on your bloodwork
Expected direction, not a measured one.
- Comprehensive Metabolic Panel (CMP) — ◆ worth watching
These are short peptide fragments given in microgram amounts and there is no mechanism predicting a specific marker shift. Listing markers here would be padding.
What to do: Test the organ system the bioregulator is aimed at, not a generic panel — that is the only measurement that would tell you anything.
The evidence base here is almost entirely one research group's, largely in Russian, and rarely replicated independently. That is the single most important thing to know before running a course, and it is more useful than any interaction list.
- How to work up to it, and when not to
- When to take it, and why that window
- Cycle length
- Time off between cycles
- Fasted or fed, and when in the day
- Needle gauge and injection site
- How the forms differ in dose
- Coach Cam's personal notes
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Everything above is free and stays free. Skool is where it becomes a plan — Svetinorm in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Svetinorm
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| hs-CRP (High-Sensitivity C-Reactive Protein) | Chronic low-grade inflammation is the process most of these target |
| ApoB (Apolipoprotein B) | Counts the particles that actually cause plaque, unlike LDL-C |
| HbA1c (Hemoglobin A1c) | Glycation, which is the other half of the ageing story |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney — the two organs that clear everything you take |
| Complete Blood Count (CBC) with Differential | The cheapest broad screen there is |
The Longevity Baseline panel covers these in one order — 13 markers, $219.10 with the discount applied.
Check results you already have → · All 103 markers A–Z
Svetinorm — frequently asked questions
What is Svetinorm?
Svetinorm (Liver peptide bioregulator) is a longevity & bioregulators research compound. Liver bioregulator — proposed to support hepatocyte function and detoxification capacity.
Is the full Svetinorm protocol on this page?
The reported research dose is on this page, along with how Svetinorm works and the evidence behind it. The protocol — how to work up to it, frequency, cycle length, time off, what not to stack it with and Coach Cam's notes — is inside Skool.
What is the half-life of Svetinorm?
Svetinorm has an approximate half-life of ~15-30 min, which is part of what determines how often it's dosed.
What forms does Svetinorm come in?
Svetinorm is available as: Injectable, Oral.
What's the evidence behind Svetinorm?
Current evidence level: Russian studies; limited. Svetinorm is offered for research purposes only and is not an approved medicine.
Svetinorm inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Svetinorm is used for
Svetinorm appears under 2 goals in the goal router.
Related Longevity & Bioregulators compounds
Where this goes next
Svetinorm is the liver, kidney & gut arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.